Abstract Details
|
Weihua Zhao, MD
(Houston Methodist Neurological Institute, Houston Methodist Hospital)
PRESENTER |
No disclosure on file |
| David R. Beers, PhD (Houston Methodist Neurological Institute) | No disclosure on file |
| Jason R. Thonhoff, MD (Houston Methodist Hospital) | Dr. Thonhoff has nothing to disclose. |
| No disclosure on file | |
| Clive Svendsen, PhD (Cedars-Sinai Medical Center) | No disclosure on file |
| Stanley H. Appel, MD, FAAN (Methodist Neurological Institute) | Dr. Appel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Appel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eledon. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Implicit. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Coya Therapeutics. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Muscular Disease Association. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Therapy Development Institute. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Finding a Cure. Dr. Appel has stock in Stock holdings in retirement acct at Fidelity. The institution of Dr. Appel has received research support from Coya Therapeutics. |